ImpediMed Limited (ASX:IPD)
Australia · Delayed Price · Currency is AUD 0.0050
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
ImpediMed Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -24.91 | -23.24 | -19.79 | -20.52 | -19.87 |
Depreciation & Amortization | 4.22 | 0.57 | 0.58 | 0.55 | 1.24 |
Other Amortization | - | 3.99 | 1.67 | 1.92 | 1.81 |
Stock-Based Compensation | 0.85 | 1.6 | -0.68 | 0.75 | 3 |
Provision & Write-off of Bad Debts | 0.1 | 0.05 | -0.23 | -0.65 | -0.45 |
Other Operating Activities | 2.81 | 0.49 | -0.02 | 0.33 | 0.4 |
Change in Accounts Receivable | -1.07 | 1.08 | 1.18 | 0.18 | 0.04 |
Change in Inventory | -1.35 | -0.1 | 0.05 | 0.12 | -0.55 |
Change in Accounts Payable | 0.44 | -0.06 | 0.12 | -0.89 | 1.53 |
Change in Other Net Operating Assets | 1.06 | 0.97 | -0.67 | 0.17 | -2.79 |
Operating Cash Flow | -17.86 | -14.65 | -17.79 | -18.05 | -15.66 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.07 | -0.06 | -0.08 | -0.39 | -0.06 |
Sale (Purchase) of Intangibles | -1.2 | -0.93 | -3.02 | -5.65 | -5.16 |
Other Investing Activities | 0.72 | - | - | - | - |
Investing Cash Flow | -0.55 | -0.99 | -3.11 | -6.04 | -5.22 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Issued | 7.68 | 15.97 | - | - | - |
Long-Term Debt Repaid | -5.31 | -0.42 | -0.48 | -0.43 | -0.37 |
Net Debt Issued (Repaid) | 2.37 | 15.55 | -0.48 | -0.43 | -0.37 |
Issuance of Common Stock | 15.3 | - | 0.06 | 30.02 | 42.5 |
Other Financing Activities | -4.66 | -1.9 | -0.06 | -1.67 | -2.21 |
Financing Cash Flow | 13.01 | 13.64 | -0.48 | 27.93 | 39.92 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -1.5 | -0.46 | 0.3 | 1.14 | 2.02 |
Net Cash Flow | -6.9 | -2.45 | -21.08 | 4.98 | 21.05 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -17.92 | -14.71 | -17.87 | -18.44 | -15.72 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -122.64% | -115.57% | -173.18% | -162.56% | -148.82% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Levered Free Cash Flow | -14.65 | -9.36 | -15.83 | -18.95 | -13.31 |
Unlevered Free Cash Flow | -11.91 | -8.63 | -15.77 | -18.93 | -13.3 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | 0.58 | - | - | - |
Change in Working Capital | -0.92 | 1.89 | 0.68 | -0.43 | -1.78 |